Core Scientific (CORZ) Shares Outstanding (Weighted Average) (2020 - 2026)

Core Scientific has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $322.9 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $322.9 million, up 2.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $322.9 million (up 2.45% YoY), and the FY2025 annual result was $318.1 million, up 24.33% from the prior year.
• Shares Outstanding (Weighted Average) came in at $322.9 million for Q1 2026 at Core Scientific, up from $318.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $382.5 million in Q3 2023 to a low of $207.1 million in Q2 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $318.0 million (2025), against an average of $313.8 million.
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 99.74% in 2022 and sank 44.9% in 2024, its largest moves.
• Core Scientific's Shares Outstanding (Weighted Average) stood at $340.6 million in 2022, then advanced by 11.51% to $379.9 million in 2023, then plunged by 32.65% to $255.8 million in 2024, then gained by 24.33% to $318.1 million in 2025, then gained by 1.52% to $322.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $322.9 million (Q1 2026), $318.1 million (Q4 2025), and $317.4 million (Q3 2025), per Business Quant data.